Akriti Gupta Jain

Akriti Jain practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Akriti Jain's NPI, 1124555198, was assigned on May 21, 2017. Akriti Jain holds Ohio license 35.148285.

Akriti Jain's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Akriti Jain's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Akriti Jain is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Akriti Jain to 3 more hospitals and 2 clinical labs, each named with a free account. Akriti Jain's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Akriti Jain practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Akriti Jain's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Akriti Jain is licensed in Ohio.

CMS data shows 620 Medicare services from Akriti Jain across 8 procedure codes in 2024, for 148 Medicare patients. Medicare paid $46,194 for them.

CMS counts 148 Medicare patients who saw Akriti Jain in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Akriti Jain's median patient age at 67, with 52% women.

In 2024, Akriti Jain wrote 518 Medicare Part D claims for 95 patients. 70% of them were for generic drugs. CMS names the drug for 335 of them, across 12 drugs with 11 or more claims each, at $1,981,222 in total drug cost. In 2020, CMS named 45 claims across 3 drugs.

Akriti Jain accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Akriti Jain as offering telehealth.

Dmand AI links 18 papers to Akriti Jain, published from 2019 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Leukemia, Myeloid, Acute, Myelodysplastic Syndromes and Antineoplastic Agents. Akriti Jain has published most often in Clin Lymphoma Myeloma Leuk. Akriti Jain's most frequent co-authors are Somedeb Ball, MD, Rami Salah-Eddin Komrokji, MD and Andrew Tucker Kuykendall, MD.

CMS Open Payments shows 85 general payments to Akriti Jain from 13 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 47% of the total. Rigel Pharmaceuticals, Inc. paid the most, $18,179. It also lists 12 research payments totaling $1,447 in 2025.